Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Todd Neale

July 25, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

L.A. McKeown

March 27, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

Advertisement

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

January 2025 Dispatch for the CV Team

December 2024 Dispatch for the CV Team

Will Semaglutide Change Cardiac Surgery? It Already Has

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Semaglutide May Ease Tobacco Use, Study Suggests

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

October 2023 News Roundup

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content